This is one of the highest-quality companies in the world. The company’s products are ubiquitous, bolstered by arguably an unrivaled user experience. The fundamentals are outstanding across the board. The company’s unequaled cash hoard of hundreds of billions of dollars seems likely to be largely used toward buybacks and dividends moving forward. Add in the possibility that shares are 27% undervalued, and you have one of the best long-term opportunities in the market for long-term dividend growth investors.
This is a high-quality healthcare firm that is positioned extremely favorably in regard to long-term, global demographic trends. These tailwinds are powerful, and the company is poised to continue pumping out growing dividends for many years to come. With the potential that shares are 15% undervalued on top of market-beating income, this is a compelling long-term dividend growth investment idea in the healthcare space.